These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27506250)

  • 1. Selenazolidine: a selenium containing proline surrogate in peptide science.
    Cordeau E; Cantel S; Gagne D; Lebrun A; Martinez J; Subra G; Enjalbal C
    Org Biomol Chem; 2016 Sep; 14(34):8101-8. PubMed ID: 27506250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new series of photoactivatable and iodinatable linear vasopressin antagonists.
    Carnazzi E; Aumelas A; Barberis C; Guillon G; Seyer R
    J Med Chem; 1994 Jun; 37(12):1841-9. PubMed ID: 8021923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of selenazolidine prodrugs of selenocysteine: toxicity, selenium levels, and glutathione peroxidase induction in A/J mice.
    Li L; Xie Y; El-Sayed WM; Szakacs JG; Roberts JC
    Life Sci; 2004 Jun; 75(4):447-59. PubMed ID: 15147831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selenazolidines as novel organoselenium delivery agents.
    Xie Y; Short MD; Cassidy PB; Roberts JC
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2911-5. PubMed ID: 11677125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic study on selenocystine-containing peptides.
    Koide T; Itoh H; Otaka A; Yasui H; Kuroda M; Esaki N; Soda K; Fujii N
    Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):502-6. PubMed ID: 8477500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aza-amino acid scanning of secondary structure suited for solid-phase peptide synthesis with fmoc chemistry and aza-amino acids with heteroatomic side chains.
    Boeglin D; Lubell WD
    J Comb Chem; 2005; 7(6):864-78. PubMed ID: 16283795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A convenient incorporation of conformationally constrained 5,5-dimethylproline into the ribonuclease A 89-124 sequence by condensation of synthetic peptide fragments.
    Cerovský V; Welker E; Scheraga HA
    J Pept Res; 2003 Mar; 61(3):140-51. PubMed ID: 12558949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper-Mediated Selenazolidine Deprotection Enables One-Pot Chemical Synthesis of Challenging Proteins.
    Zhao Z; Metanis N
    Angew Chem Int Ed Engl; 2019 Oct; 58(41):14610-14614. PubMed ID: 31408267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent pseudo-peptide linear vasopressin antagonists: design, synthesis, and applications.
    Durroux T; Peter M; Turcatti G; Chollet A; Balestre MN; Barberis C; Seyer R
    J Med Chem; 1999 Apr; 42(7):1312-9. PubMed ID: 10197974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
    J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of selenazolidine prodrugs of selenocysteine: toxicity and glutathione peroxidase induction in V79 cells.
    Short MD; Xie Y; Li L; Cassidy PB; Roberts JC
    J Med Chem; 2003 Jul; 46(15):3308-13. PubMed ID: 12852761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin V1a and V1b receptor modulators: a patent review (2012 - 2014).
    Ślusarz MJ
    Expert Opin Ther Pat; 2015 Jun; 25(6):711-22. PubMed ID: 25776143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and peptide bond orientation in tetrapeptides containing L-azetidine-2-carboxylic acid and L-proline.
    Tsai FH; Overberger CG; Zand R
    Biopolymers; 1990; 30(11-12):1039-49. PubMed ID: 2081265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New t-butyl based aspartate protecting groups preventing aspartimide formation in Fmoc SPPS.
    Behrendt R; Huber S; Martí R; White P
    J Pept Sci; 2015 Aug; 21(8):680-7. PubMed ID: 26077723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of potent, highly selective vasopressin hypotensive agonists.
    Stoev S; Cheng LL; Manning M; Wo NC; Szeto HH
    J Pept Sci; 2006 Sep; 12(9):592-604. PubMed ID: 16625682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fmoc-Sec(Xan)-OH: synthesis and utility of Fmoc selenocysteine SPPS derivatives with acid-labile sidechain protection.
    Flemer S
    J Pept Sci; 2015 Jan; 21(1):53-9. PubMed ID: 25504629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformations of heterochiral and homochiral proline-pseudoproline segments in peptides: context dependent cis-trans peptide bond isomerization.
    ; Raghothama S; Raghavender US; Aravinda S; Shamala N; Balaram P
    Biopolymers; 2009; 92(5):405-16. PubMed ID: 19373926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic procedure for N-Fmoc amino acyl-N-sulfanylethylaniline linker as crypto-peptide thioester precursor with application to native chemical ligation.
    Sakamoto K; Sato K; Shigenaga A; Tsuji K; Tsuda S; Hibino H; Nishiuchi Y; Otaka A
    J Org Chem; 2012 Aug; 77(16):6948-58. PubMed ID: 22816612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and chromatographic properties of selenazolidine-2-carboxylic acid (beta-selenaproline).
    De Marco C; Cini C; Coccia R; Blarzino C
    Ital J Biochem; 1979; 28(2):104-10. PubMed ID: 553899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.